An Open-Label, Pharmacokinetic and Safety Study of Travoprost Ophthalmic Solution, 0.004% in Pediatric Glaucoma or Ocular Hypertension Patients

drug protocol number
C-12-009
drug sponsor
Alcon
drug study
Travoprost 0.004%
drug trial site
KKESH
drug status
Completed
drug phase